Synthetic lethality may help overcome cancer therapeutic resistance by exploiting tumour vulnerabilities, supported by ...

Meta-analysis links prior tuberculosis and chronic bronchitis to higher lung cancer risk in never-smokers, with implications ...

Move strengthens Elephas’ scientific and clinical leadership ahead of commercial launch of its live tumor immunology platform ...

Study Results Support the use of TellDx to Personalize Cancer Care Management – -- Clinical study published in Cancer Discovery -- ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio, Inc., a ...

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...

A new tool to classify pancreatic cancer subtypes will help clinicians and researchers overcome the challenges posed by the ...

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by remarkable cellular ...

A big challenge when treating and researching pancreatic cancer is its heterogeneity: the degree of aggressiveness of the ...

Biological heterogeneity in autism can illuminate precision psychiatry and improve insights from primate brain mapping data.

A biotechnology and AI-enabled drug discovery company based in the San Francisco Bay Area, California. The company operates a ...

Investigators conducted a systematic review assessing the efficacy of positive psychology interventions for patients and survivors across various stages and types of cancer.

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...